Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Tilray Inc (TLRY)

Tilray Inc (TLRY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,140,378
  • Shares Outstanding, K 97,645
  • Annual Sales, $ 43,130 K
  • Annual Income, $ -67,720 K
  • 60-Month Beta 4.32
  • Price/Sales 53.02
  • Price/Cash Flow N/A
  • Price/Book 6.01

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.29
  • Number of Estimates 8
  • High Estimate -0.22
  • Low Estimate -0.39
  • Prior Year -0.20
  • Growth Rate Est. (year over year) -45.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.20 +6.78%
on 10/14/19
25.68 -16.02%
on 10/24/19
+0.61 (+2.91%)
since 10/11/19
3-Month
20.20 +6.78%
on 10/14/19
46.25 -53.36%
on 08/13/19
-20.89 (-49.20%)
since 08/12/19
52-Week
20.20 +6.78%
on 10/14/19
120.40 -82.08%
on 11/26/18
-91.87 (-80.99%)
since 11/12/18

Most Recent Stories

More News
Tilray, Inc. (TLRY) Reports Q3 Loss, Tops Revenue Estimates

Tilray, Inc. (TLRY) delivered earnings and revenue surprises of -72.41% and 3.05%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

TLRY : 21.57 (-1.60%)
Financial Institutions Take Note of Cannabis Market's Glowing Potential

The rapid emergence of the cannabis industry has finally caught Wall Street's attention as numerous analysts have initiated their coverage on the marketplace. Notably, firms such as RBC Capital Markets,...

FISI : 32.20 (+0.34%)
CRFTF : 0.1350 (unch)
CRFT.CN : 0.175 (-2.78%)
TLRY : 21.57 (-1.60%)
NEPT : 3.12 (+5.76%)
NEPT.TO : 4.11 (+5.38%)
MMNFF : 1.0500 (-3.76%)
MMEN.CN : 1.370 (-5.52%)
SPRWF : 0.6600 (+1.54%)
FIRE.TO : 0.89 (+3.49%)
5 Trendy Earnings Charts

Are cannabis and solar stocks still the place to be for traders in 2019?

CSIQ : 17.51 (+3.82%)
CGC : 19.25 (-5.17%)
TLRY : 21.57 (-1.60%)
CRON : 7.83 (-3.09%)
ACB : 3.57 (-1.38%)
Chegg, C.H. Robinson Worldwide, Tilray, Anheuser-Busch InBev and Novartis highlighted as Zacks Bull and Bear of the Day

Chegg, C.H. Robinson Worldwide, Tilray, Anheuser-Busch InBev and Novartis highlighted as Zacks Bull and Bear of the Day

CHRW : 75.50 (-1.77%)
CHGG : 35.34 (+1.52%)
NVS : 89.29 (+0.74%)
BUD : 79.08 (+0.47%)
TLRY : 21.57 (-1.60%)
Tilray (TLRY) Set to Report Q3 Results: Will the Stock Continue to Plunge?

Tilray (TLRY) is set to report its third quarter results after the closing bell Tuesday, November 12.

NVS : 89.29 (+0.74%)
BUD : 79.08 (+0.47%)
TLRY : 21.57 (-1.60%)
IntelGenx Reports Third Quarter 2019 Financial Results

IntelGenx Technologies Corp. (TSX-V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today reported financial results for the third quarter ended September 30, 2019. All...

IGX.VN : 0.770 (-1.28%)
IGXT : 0.5800 (-2.11%)
TLRY : 21.57 (-1.60%)
U.S.-China Trade Progress, Q3 Earnings Results & Buy Yeti Stock - Free Lunch

The latest U.S.-China trade war news that could see the world's two largest economies roll back tariffs. Q3 earnings results from the likes of Qualcomm and Square. And why Yeti is a Zacks Rank #1 (Strong...

DIS : 138.58 (+1.35%)
TRIP : 31.70 (-0.16%)
EXPE : 95.66 (-3.44%)
NFLX : 292.01 (-0.74%)
AMZN : 1,778.00 (+0.36%)
SQ : 61.54 (-3.53%)
QCOM : 90.97 (-0.95%)
AAPL : 261.81 (-0.15%)
LULU : 207.81 (+0.30%)
RL : 111.36 (-2.32%)
CGC : 19.25 (-5.17%)
ACB : 3.57 (-1.38%)
CRON : 7.83 (-3.09%)
TLRY : 21.57 (-1.60%)
Y : 781.43 (+0.13%)
Pay Attention to Hard to Borrow Rates, Even in Options Trades

Pay Attention to Hard to Borrow Rates, Even in Options Trades

TLRY : 21.57 (-1.60%)
MSFT : 147.07 (+0.66%)
Tilray (TLRY) to Report Q3 Earnings: What's in the Cards?

Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports third-quarter 2019 results.

FOLD : 9.23 (-0.54%)
CGC : 19.25 (-5.17%)
EYEN : 2.67 (-7.29%)
TLRY : 21.57 (-1.60%)
Why Johns Hopkins Medicine has Just Begun to Research Psilocybin Mushrooms

This has been a big year for psilocybin mushrooms, with Denver and Oakland legalizing its use. While the federal government still classifies it as dangerous, clinical evidence reveals that it does hold...

BOSS.CN : 0.295 (+5.36%)
BOSQF : 0.2192 (-0.23%)
FIRE.TO : 0.89 (+3.49%)
SPRWF : 0.6600 (+1.54%)
CL.CN : 8.450 (-0.59%)
CRLBF : 6.3775 (-0.66%)
TLRY : 21.57 (-1.60%)
CRON : 7.83 (-3.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

See More Share

Trade TLRY with:

Business Summary

Tilray, Inc. is a pharmaceutical company. It develops cannabis based medicines, drugs, drops and oil products. Tilray, Inc. is based in NANAIMO, Canada.

See More

Key Turning Points

2nd Resistance Point 22.52
1st Resistance Point 22.05
Last Price 21.57
1st Support Level 20.95
2nd Support Level 20.32

See More

52-Week High 120.40
Fibonacci 61.8% 82.12
Fibonacci 50% 70.30
Fibonacci 38.2% 58.48
Last Price 21.57
52-Week Low 20.20

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar